Skip to main content

Specialty Pharmacy

  • Walgreens: HIV-specialized pharmacies improve adherence, save money

    ATLANTA - Patients using HIV-specialized pharmacies were more likely to use regimens on guideline with HHS recommendations than those not using HIV-specialized pharmacies (81.6% as compared to 76.9%), according to a Walgreens study presented this week before the Association of Nurses in AIDS Care 2016 conference here.

  • Avella Specialty Pharmacy adds medical advisor

    PHOENIX, Ariz. — Avella Specialty Pharmacy has added Dr. Joel V. Brill as a medical advisor, the organization announced Friday. Brill will bring more than 30 years of clinical and leadership experience, as well as expertise in value-based care and advanced payment models to the company. 
     

  • AmerisourceBergen to build corporate campus in Texas

    CARROLLTON, Texas — AmerisourceBergen Specialty Group recently announced that it would be building a 300,000-sq. ft. corporate campus at the Offices of Austin Ranch here, which will make it one of the largest employees in Carrollton. It will serve as AmerisourceBergen Specialty Group’s new regional headquarters. 
     

  • Mylan, Biocon submit application for Herceptin biosimilar

    PITTSBURGH and BENGALURU, India — Mylan and Biocon on Tuesday announced that they had submitted a biologics license application to the Food and Drug Administration for their proposed biosimilar of Herceptin (trastuzumab). The companies believe their submission has the potential to be the first of a proposed biosimilar for the drug in the United States. 
     

  • McKesson Specialty Health’s solution center gets BenchmarkPortal certification

    SCOTTSDALE, Ariz. — McKesson Specialty Health on Thursday announced that for the eighth year running, its Reimbursement, Access & Safety Services Solution Center has been certified as a Center of Excellence by call center research and consulting organization BenchmarkPortal. 
     

  • Diplomat’s profit, margin feel impact of DIR fees in Q3

    FLINT, Mich. — Diplomat Pharmacy on Wednesday shared the financial results for its third quarter ended Sept. 30, showing increases in revenue and dispensed prescriptions, but alongside a drop in profit per prescription dispensed and its gross margin. 
     

  • Benzer Pharmacy to dispense Cosentyx

    TAMPA, Fla. — Benzer Pharmacy announced Thursday that it had been chosen to order Novartis’s limited distribution drug Cosentyx, a treatment plaque psoriasis, psoriatic arthritis and ankylosing spondylitis 
     
    “We are excited about this privilege as this is a limited-distribution drug which is only available through a selected few specialty pharmacies.” Benzer Pharmacy chief clinical officer Lindsay Wall said.
     

  • Allergan completes Tobira Therapeutics acquisition

     
    DUBLIN — Allergan’s has completed its $1.7 billion acquisition of clinical-stage biopharma company Tobira Therapeutics, the company announced Tuesday. Tobira focuses on developing and commercializing treatments for non-alcoholic steatohepatitis (NASH) and other liver diseases. Allergan paid $28.35 per share of the company, as well as contingent value rights, potentially payable upon completion of certain development, regulatory and commercial milestones. 
     
X
This ad will auto-close in 10 seconds